SEARCH

SEARCH BY CITATION

REFERENCES

  • De Alarcon, P.A., Patil, S., Golberg, J., Allen, J.B. & Shaw, S. (1987) Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder. Cancer, 60, 987993.
  • Al-Kasim, F., Doyle, J., Massey, G., Weinstein, H.J. & Zipursky, A. (2002) Incidence and treatment of potentially lethal disease in transient leukemia of Down Syndrome: a Pediatric Oncology group study. Journal of Pediatric Hematology and Oncology, 24, 913.
  • Athale, U.H., Razzouk, B.I., Raimondi, S.C., Tong, X., Behm, F.G., Head, D.R., Srivastava, D.K., Rubnitz, J.E., Bowman, L., Pui, C.H. & Ribeiro, R.C. (2001) Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood, 97, 37273732.
  • Becroft, D.M.O. & Zwi, J. (1990) Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Pediatric Pathology, 10, 397406.
  • Bonno, M., Azuma, E., Kawasaki, H., Zhang, X.-L., Komada, Y., Hirayama, M., Higashigawa, M., Umemoto, U., Koike, T., Kato, T., Tahara, T., Miyazaki, H. & Sakurai, M. (1998) Thrombopoietin level is inversely related to blast count, not platelet number, in Down Syndrome neonates with transient myeloproliferative disorder. American Journal of Hematology, 58, 267272.
  • Bozner, P. (2002) Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Archives of Pathology and Laboratory Medicine, 126, 474477.
  • Bresters, D., Reus, A.C.W., Veerman, A.J.P., Van Wering, E.R., Van der Does-Van den Berg, A. & Kaspers, G.J.L. (2002) Congenital Leukaemia:: the Dutch experience and review of the literature. British Journal of Haematology, 117, 513524.
  • Breton-Gorius, J. & Guichard, J. (1972) Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. American Journal of Pathology, 66, 277293.
  • Dastugue, N., Lafage-Pochitaloff, M., Pages, M.P., Radford, I., Bastard, C., Talmant, P., Mozziconacci, M.J., Leonard, C., Bilhou-Nabera, C., Cabrol, C., Capodano, A.M., Cornillet-Lefebvre, P., Lessard, M., Mugneret, F., Perot, C., Taviaux, S., Fenneteaux, O., Duchayne, E. & Berger, R. (2002) Cytogenetic profile of childhood and adult megakaryoblastic leukaemia: a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood, 100, 618626.
  • Debili, N., Coulombbel, L., Croiselle, L., Katz, A., Guichard, J., Breton-Gorius, J. & Vainchenker, W. (1996) Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood, 88, 12841296.
  • Doyle, J.J. & Zipursky, A. (1994) Down Syndrome children with neonatal transient leukemia. Survival and risk of subsequent myelodysplasia and leukemia. Blood, 84, 316a.
  • Doyle, J.J., Thorner, P., Poon, A., Tanswell, K., Kamel-Reid, S. & Zipursky, A. (1995) Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome. Leukemia and Lymphoma, 17, 345350.
  • Duflos-Delaplace, D., Lai, J.-L., Nelken, B., Genevieve, F., Defachelles, A.-S. & Zandecki, M. (1999) Transient leukemoid disorder in a newborn with Down Syndrome followed 19 months later by an acute myeloid leukemia: demonstration of the same structural change in both instances with clonal evolution. Cancer Genetics and Cytogenetics, 131, 166171.
  • Eguchi, M., Sakaibara, H., Suda, J., Ozawa, T., Hayashi, Y., Sato, T., Kojima, S. & Furukawa, T. (1989) Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome. British Journal of Haematology, 73, 315322.
  • Engel, R.R., Hammond, D., Eitzman, D.V., Pearson, H. & Krivit, W. (1964) Transient congenital leukemia in 7 infants with mongolism. Journal of Pediatrics, 65, 303306.
  • Faed, M.J.W., Robertson, J., Todd, A.Z., Sivakumaran, M. & Tarnow-Modi, W.O. (1990) Trisomy 21 in transient myeloproliferative disorder. Cancer Genetics and Cytogenetics, 48, 250264.
  • Girodon, F., Favre, B., Couillaud, G., Carli, P.M., Parmeland, C. & Maynadie, M. (2000) Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21. Cytometry, 42, 118122.
  • Hattori, H., Matsuzaki, A., Suminoe, A., Ihara, K., Nakayama, H. & Hara, T. (2001) High expression of PDG-B and transforming growth factor-1 blasts cells from patients with Down Syndrome suffering from transient myeloproliferative syndrome and organ fibrosis. British Journal of Haematology, 115, 472475.
  • Hendricks, S., Sorensen, T. & Baker, E. (1993) Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder. Obstetrics and Gynecology, 82, 703705.
  • Hirashima, C., Eguchi, Y., Kohmura, Y., Minikami, H. & Sato, I. (2000) Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down Syndrome. Journal of Obstetrics and Gynaecologic Research, 26, 303306.
  • Holt, S.E., Brown, E.J. & Zipursky, A. (2002) Telomerase and the benign and malignant megakaryoblastic leukemias of Down Syndrome. Journal of Pediatric Hematology and Oncology, 24, 1417.
  • Homans, A.C., Verissimo, A.M. & Vlacha, V. (1993) Transient abnormal myelopoiesis of infancy associated with trisomy 21. American Journal of Pediatric Hematology and Oncology, 15, 392399.
  • Honda, F., Punnett, H.H., Charney, E., Miller, G. & Thiede, H.A. (1964) Serial cytogenetic and hematologic studies on a mongel with trisomy 21 and acute congenital leukemia. Journal of Pediatrics, 65, 880887.
  • Hsu, L.Y. & Perlis, T.E. (1984) United States survey on chromosome mosaicism and pseudomosaicism in prenatal diagnosis. Prenatal Diagnosis, 4, 97130.
  • Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. (1995) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. British Journal of Haematology, 90, 607614.
  • Karandikar, N.J., Aquino, D.B., McKenna, R.W. & Kroft, S.H. (2001) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. American Journal of Clincal Pathology, 116, 204210.
  • Kempski, H.M., Chessells, J.M. & Reeves, B.R. (1997) Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia. Leukemia, 11, 19731977.
  • Kempski, H.M., Craze, J.L., Chessells, J.M. & Reeves, B.R. (1998) Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study. British Journal of Haematology, 103, 473479.
  • Koike, T., Aoki, S., Maruyama, S., Narita, M., Ishizuka, T., Imanaka, H., Adachi, T., Maeda, H. & Shibata, A. (1987) Cell surface phenotyping of megakaryoblasts. Blood, 69, 957960.
  • Kounami, S., Aoyagi, N., Tsuno, H., Suzuky, H., Kitano, N. & Koike, M. (1997) Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome. Acta Haematologica, 98, 109112.
  • Kurahashi, H., Hara, J., Yumura-Yagi, K., Murayama, N., Inoue, M., Ishihara, S., Tawa, A., Okada, S. & Kawa-Ha, K. (1991) Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood, 77, 11611163.
  • Kurahashi, H., Hara, J., Yumura-Yagi, K., Tawa, A. & Kawa-Ha, K. (1992) Transient abnormal myelopoiesis in Down's syndrome. Leukemia and Lymphoma, 8, 465475.
  • Lange, B. (2000) The management of neoplastic disorders of haematopoiesis in children with Down's Syndrome. British Journal of Haematology, 110, 512524.
  • Liang, D.-C., Ma, S.-W., Lu, T.-H. & Lin, S.-T. (1993) Transient myeloproliferative disorder and acute myeloid leukemia: study of six neonatal cases with long-term follow-up. Leukemia, 7, 15211524.
  • Lu, G., Altman, A.J. & Benn, P.A. (1993) Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several. Cancer Genetics and Cytogenetics, 67, 8189.
  • Ma, Z., Morris, S.W., Valentine, V., Li, M., Herbrick, J.A., Cui, X., Bouman, D., Li, Y., Mehta, P.K., Nizetic, D., Kaneko, Y., Chan, G.C., Chan, L.C., Squire, J., Scherer, S.W. & Hitzler, J.K. (2001a) Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nature Genetics, 28, 220221.
  • Ma, S.K., Wan, T.S.K., Chan, G.C.F., Ha, S.Y., Fung, L.F. & Chan, L.C. (2001b) Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down Syndrome. British Journal of Haematology, 112, 824827.
  • Malkin, D., Brown, E.J. & Zipursky, A. (2000) The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genetics and Cytogenetics, 116, 15.
  • Miyashita, T., Asada, M., Fujimoto, J., Inaba, T., Takihara, Y., Sugita, K., Bessho, F., Furukawa, T. & Mizutani, S. (1991) Clonal analysis of transient myeloproliferative disorder in Down's syndrome. Leukemia, 5, 5659.
  • Miyauchi, J., Ito y, Kawano, T., Tsunematsu, Y. & Shimizu, K. (1992) Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis. Blood, 80, 15211527.
  • Mora, J., Dobrenic, A.M., Bussel, J.B. & Aledo, A. (2000) Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins. Medical Pediatric Oncology, 35, 110113.
  • Nijhawan, A., Baselga, E., Gonzalez-Ensenat, M.A., Vicente, A., Southern, J.F., Camitta, B.M., Esterly, N.B. & Drolet, B.A. (2001) Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Archives of Dermatology, 137, 760763.
  • Polski, J.M., Galambos, C., Gale, G.B.C., Dunphy, C.H., Evans, H.L., Batanian, J. & R. (2002) Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. Journal of Pediatric Hematology and Oncology, 24, 5054.
  • Rogers, P.C., Kalousek, D.K., Denegri, J.F., Thomas, J.W. & Baker, M.A. (1983) Neonate with Down's Syndrome and transient congenital leukemia. In vitro studies. American Journal of Pediatric Hematology and Oncology, 5, 5964.
  • Ruchelli, E.D., Uri, A., Dimmick, J.E., Bove, K.E., Huff, D.S., Duncan, L.M., Jennings, J.B. & Witzleben, C.L. (1991) Severe perinatal liver disease and Down syndrome: An apparent relationship. Human Pathology, 22, 12741280.
  • Schaison, G., Daniel, M.T., Bergefr, R. & Baruchel, A. (1990) De novo acute megakaryoblastic leukemia (AMKL) in children. A study of 22 cases. Blood, 76, 316a.
  • Shiffer, J. & Natarajan, S. (2001) Transient myeloproliferative disorder in Down Syndrome presenting with ascites: a case report. Acta Cytologica, 45, 610612.
  • Shivdasani, R.A. (2001) Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells, 19, 397407.
  • Slayton, W.B., Spangrude, G.J., Chen, Z., Greene, W.F. & Virshup, D. (2002) Lineage-specific trisomy 21 in a neonate with resolving transient myeloproliferative syndrome. Journal of Pediatric Hematology and Oncology, 24, 224226.
  • Smrcek, J.M., Baschat, A.A., Germer, U., Gloeckner-Hotmann, K. & Gembruch, U. (2001) Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21. Ultrasound Obstetrics and Gynecology, 17, 403409.
  • Suda, J., Eguchi, M., Akiyama, Y., Iwama, Y., Furukawa, T., Sato, Y., Miura, Y., Suda, T. & Saito, M. (1987) Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder. Blood, 69, 508512.
  • Suda, J., Eguchi, M., Ozawa, T., Furukawa, T., Hayashi, Y., Kojima, S., Maeda, H., Tadokoro, K., Sato, Y., Miura, Y., Ohara, A. & Suda, T. (1988) Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's Syndrome. British Journal of Haematology, 68, 181187.
  • De Tar, M.W., Dittman, W. & Gilbert, J. (2000) Transient myeloproliferative disease of the newborn: case report with placental, cytogenetic, and flow cytometric findings. Human Pathology, 31, 396398.
  • Tchernia, G., Lejeune, F., Boccara, J.F., Denavit, M.F., Dommergues, J.P. & Bernaudin, F. (1996) Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine. Journal of Pediatric Hematology and Oncology, 18, 5962.
  • Terui, T., Niitsu, Y., Mahara, K., Fujisaki, Y., Urushizaki, Y., Mogi, Y., Kohgo, Y., Watanabe, N., Ogura, M. & Saito, H. (1990) The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood, 75, 15401548.
  • Wechsler, J., Greene, M., McDevitt, M., Anastasi, J., Karp, J.E., LeBeau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA 1 in the megakaryoblastic leukemia of Down Syndrome. Nature Genetics published on line. 12 August 2002, doi: 10.. 1038/ng955.
  • Worth, L.L., Zipursky, A., Christensen, H. & Tubergen, D. (1999) Transient leukemia with extreme basophilia in a phenotypically normal infant with blast cells containing a pseudodiploid clone, 46,XY i (21) (q10). Journal of Pediatric Hematology and Oncology, 21, 6366.
  • Worton, R.G. & Stern, R. (1994) A Canadian collaborative study of mosaicism in amniotic fluid. Prenatal Diagnosis 4, Spec no. 131–144.
  • Yumura-Yagi, K., Hara, J., Kuruhashi, J., Nishiura, T., Kaneyama, Y., Osugi, Y., Sakata, N., Inoue, M., Tawa, A., Okada, S. & Kawa-Ho, K. (1992) Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's Syndrome. British Journal of Haematology, 81, 520525.
  • Yumura-Yagi, K., Hara, J., Tawa, A. & Kawa, H.A.K. (1994) Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis. Leukemia and Lymphoma, 13, 393400.
  • Zipursky, A. (1996) The treatment of children with acute megakaryoblastic leukemia who have Down syndrome. Journal of Pediatric Hematology and Oncology, 18, 1012.
  • Zipursky, A. & Doyle, J. (1993) Leukemia in newborn infants with Down syndrome [letter]. Leukemia Research, 17, 195.
  • Zipursky, A., Poon, A. & Doyle, J. (1992a) Leukemia in Down's Syndrome. A Review. Pediatric Hematology and Oncology, 9, 139149.
  • Zipursky, A., Doyle, J., Christensen, H., De Harven, E. & Freedman, M.H. (1992b) Leukemic cells in the transient leukemia of Down syndrome. Blood, 80, 32a.
  • Zipursky, A., Thorner, P., De Harven, E., Christensen, H. & Doyle, J. (1994) Myelodysplasia and acute megakaryoblastic leukemia in Down Syndrome. Leukemia and Lymphoma, 18, 163171.
  • Zipursky, A., Christensen, H. & De Harven, E. (1995) Ultrastructural studies of the megakaryoblastic leukemias of Down Syndrome. Leukemia and Lymphoma, 18, 341347.
  • Zipursky, A., Rose, T., Skidmore, M., Thorner, P. & Doyle, J. (1996) Hydrops fetalis and neonatal leukemia in Down syndrome. Pediatric Hematology and Oncology, 13, 8187.
  • Zipursky, A., Brown, E., Christensen, H., Sutherland, R. & Doyle, J. (1997) Leukemia and/or Myeloproliferative syndrome in neonates with Down Syndrome. Seminars in Perinatology, 21, 97101.
  • Zipursky, A., Brown, E.J., Christensen, H. & Doyle, J. (1999) Transient myeloproliferative disorder [Transient leukemia] and hematological manifestation of Down syndrome. Clinics in Laboratory Medicine, 19, 157167.
  • Zon, L.I., Yamaguchi, Y., Yee, K., Albee, E.A., Kimura, A., Bennett, J.C., Orkin, S.H. & Ackerman, S.J. (1993) Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood, 81, 32343241.